Software - Application
Compare Stocks
2 / 10Stock Comparison
RMNI vs USPH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
RMNI vs USPH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Software - Application | Medical - Care Facilities |
| Market Cap | $362M | $897M |
| Revenue (TTM) | $423M | $695M |
| Net Income (TTM) | $35M | $11M |
| Gross Margin | 59.9% | 22.0% |
| Operating Margin | 13.7% | 12.2% |
| Forward P/E | 11.3x | 20.6x |
| Total Debt | $28M | $426M |
| Cash & Equiv. | $120M | $36M |
RMNI vs USPH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Rimini Street, Inc. (RMNI) | 100 | 87.2 | -12.8% |
| U.S. Physical Thera… (USPH) | 100 | 80.0 | -20.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RMNI vs USPH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RMNI carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (11.3x vs 20.6x)
- 8.3% margin vs USPH's 1.5%
- +18.3% vs USPH's -14.3%
USPH is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.93, yield 3.1%
- Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
- 22.6% 10Y total return vs RMNI's -60.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.3% revenue growth vs RMNI's -1.7% | |
| Value | Lower P/E (11.3x vs 20.6x) | |
| Quality / Margins | 8.3% margin vs USPH's 1.5% | |
| Stability / Safety | Beta 0.93 vs RMNI's 1.44 | |
| Dividends | 3.1% yield; 5-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +18.3% vs USPH's -14.3% | |
| Efficiency (ROA) | 8.9% ROA vs USPH's 0.9% |
RMNI vs USPH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RMNI vs USPH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
RMNI leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
USPH is the larger business by revenue, generating $695M annually — 1.6x RMNI's $423M. RMNI is the more profitable business, keeping 8.3% of every revenue dollar as net income compared to USPH's 1.5%. On growth, USPH holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $423M | $695M |
| EBITDAEarnings before interest/tax | $63M | $107M |
| Net IncomeAfter-tax profit | $35M | $11M |
| Free Cash FlowCash after capex | $47M | $67M |
| Gross MarginGross profit ÷ Revenue | +59.9% | +22.0% |
| Operating MarginEBIT ÷ Revenue | +13.7% | +12.2% |
| Net MarginNet income ÷ Revenue | +8.3% | +1.5% |
| FCF MarginFCF ÷ Revenue | +11.0% | +9.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.2% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -72.1% | -115.0% |
Valuation Metrics
RMNI leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
At 10.1x trailing earnings, RMNI trades at a 76% valuation discount to USPH's 41.5x P/E. On an enterprise value basis, RMNI's 7.3x EV/EBITDA is more attractive than USPH's 12.5x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $362M | $897M |
| Enterprise ValueMkt cap + debt − cash | $269M | $1.3B |
| Trailing P/EPrice ÷ TTM EPS | 10.10x | 41.55x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.32x | 20.63x |
| PEG RatioP/E ÷ EPS growth rate | 0.52x | — |
| EV / EBITDAEnterprise value multiple | 7.30x | 12.52x |
| Price / SalesMarket cap ÷ Revenue | 0.86x | 1.15x |
| Price / BookPrice ÷ Book value/share | — | 1.16x |
| Price / FCFMarket cap ÷ FCF | 6.50x | 14.71x |
Profitability & Efficiency
RMNI leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), RMNI scores 6/9 vs USPH's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +1.4% |
| ROA (TTM)Return on assets | +8.9% | +0.9% |
| ROICReturn on invested capital | — | +5.6% |
| ROCEReturn on capital employed | +55.0% | +7.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | — | 0.55x |
| Net DebtTotal debt minus cash | -$92M | $390M |
| Cash & Equiv.Liquid assets | $120M | $36M |
| Total DebtShort + long-term debt | $28M | $426M |
| Interest CoverageEBIT ÷ Interest expense | 16.13x | 15.42x |
Total Returns (Dividends Reinvested)
RMNI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in USPH five years ago would be worth $5,664 today (with dividends reinvested), compared to $5,032 for RMNI. Over the past 12 months, RMNI leads with a +18.3% total return vs USPH's -14.3%. The 3-year compound annual growth rate (CAGR) favors RMNI at -0.4% vs USPH's -17.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +3.7% | -24.6% |
| 1-Year ReturnPast 12 months | +18.3% | -14.3% |
| 3-Year ReturnCumulative with dividends | -1.3% | -43.7% |
| 5-Year ReturnCumulative with dividends | -49.7% | -43.4% |
| 10-Year ReturnCumulative with dividends | -60.1% | +22.6% |
| CAGR (3Y)Annualised 3-year return | -0.4% | -17.4% |
Risk & Volatility
Evenly matched — RMNI and USPH each lead in 1 of 2 comparable metrics.
Risk & Volatility
USPH is the less volatile stock with a 0.93 beta — it tends to amplify market swings less than RMNI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RMNI currently trades 73.2% from its 52-week high vs USPH's 63.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.53x | 1.00x |
| 52-Week HighHighest price in past year | $5.38 | $93.50 |
| 52-Week LowLowest price in past year | $2.87 | $58.55 |
| % of 52W HighCurrent price vs 52-week peak | +73.2% | +63.1% |
| RSI (14)Momentum oscillator 0–100 | 62.5 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 365K | 171K |
Analyst Outlook
USPH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates RMNI as "Hold" and USPH as "Buy". Consensus price targets imply 82.0% upside for RMNI (target: $7) vs 72.9% for USPH (target: $102). USPH is the only dividend payer here at 3.06% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $7.17 | $102.00 |
| # AnalystsCovering analysts | 5 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% |
| Dividend StreakConsecutive years of raises | 0 | 5 |
| Dividend / ShareAnnual DPS | — | $1.80 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | +0.6% |
RMNI leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). USPH leads in 1 (Analyst Outlook). 1 tied.
RMNI vs USPH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is RMNI or USPH a better buy right now?
For growth investors, U.
S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -1. 7% for Rimini Street, Inc. (RMNI). Rimini Street, Inc. (RMNI) offers the better valuation at 10. 1x trailing P/E (11. 3x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RMNI or USPH?
On trailing P/E, Rimini Street, Inc.
(RMNI) is the cheapest at 10. 1x versus U. S. Physical Therapy, Inc. at 41. 5x. On forward P/E, Rimini Street, Inc. is actually cheaper at 11. 3x.
03Which is the better long-term investment — RMNI or USPH?
Over the past 5 years, U.
S. Physical Therapy, Inc. (USPH) delivered a total return of -43. 4%, compared to -49. 7% for Rimini Street, Inc. (RMNI). Over 10 years, the gap is even starker: USPH returned +23. 1% versus RMNI's -59. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RMNI or USPH?
By beta (market sensitivity over 5 years), U.
S. Physical Therapy, Inc. (USPH) is the lower-risk stock at 1. 00β versus Rimini Street, Inc. 's 1. 53β — meaning RMNI is approximately 53% more volatile than USPH relative to the S&P 500.
05Which is growing faster — RMNI or USPH?
By revenue growth (latest reported year), U.
S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -1. 7% for Rimini Street, Inc. (RMNI). On earnings-per-share growth, the picture is similar: Rimini Street, Inc. grew EPS 197. 5% year-over-year, compared to -22. 8% for U. S. Physical Therapy, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RMNI or USPH?
Rimini Street, Inc.
(RMNI) is the more profitable company, earning 8. 8% net margin versus 1. 9% for U. S. Physical Therapy, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus 7. 8% for RMNI. At the gross margin level — before operating expenses — RMNI leads at 60. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RMNI or USPH more undervalued right now?
On forward earnings alone, Rimini Street, Inc.
(RMNI) trades at 11. 3x forward P/E versus 20. 6x for U. S. Physical Therapy, Inc. — 9. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for RMNI: 82. 0% to $7. 17.
08Which pays a better dividend — RMNI or USPH?
In this comparison, USPH (3.
1% yield) pays a dividend. RMNI does not pay a meaningful dividend and should not be held primarily for income.
09Is RMNI or USPH better for a retirement portfolio?
For long-horizon retirement investors, U.
S. Physical Therapy, Inc. (USPH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), 3. 1% yield). Rimini Street, Inc. (RMNI) carries a higher beta of 1. 53 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (USPH: +23. 1%, RMNI: -59. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RMNI and USPH?
These companies operate in different sectors (RMNI (Technology) and USPH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RMNI is a small-cap deep-value stock; USPH is a small-cap high-growth stock. USPH pays a dividend while RMNI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.